Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""adenocarcinoma"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 165385
Tytuł:
The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung.
Autorzy:
Kong C; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
Yin X; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
Zou J; Department of Graduate, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, China.; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China.
Ma C; Department of Radiation Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 250117, Jinan, Shandong Province, China. machangsheng_.
Liu K; Department of Head and Neck Comprehensive Radiotherapy, Affiliated Tumor Hospital of Xinjiang Medical University, 830000, Urumqi, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 454. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/genetics
Adenocarcinoma*/genetics
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Brain Neoplasms*/diagnostic imaging
Humans ; Positron Emission Tomography Computed Tomography ; Retrospective Studies ; Lung/pathology ; ErbB Receptors/genetics ; Machine Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
DIEANet: an attention model for histopathological image grading of lung adenocarcinoma based on dimensional information embedding.
Autorzy:
Wang Z; College of Software, Xinjiang University, Urumqi, 830046, China.
Gao J; Xinjiang Key Laboratory of Clinical Genetic Testing and Biomedical Information, Karamay, 834099, China.; Xinjiang Clinical Research Center for Precision Medicine of Digestive System Tumor, Karamay, 834099, China.; Department of Pathology, Karamay Central Hospital, Karamay, 834099, China.
Li M; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China.; Key Laboratory of Signal Detection and Processing, Xinjiang University, Urumqi, 830046, China.
Zuo E; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China.; Xinjiang Cloud Computing Application Laboratory, Karamay, 834099, China.
Chen C; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China.; Xinjiang Cloud Computing Application Laboratory, Karamay, 834099, China.
Chen C; College of Software, Xinjiang University, Urumqi, 830046, China.
Liang F; Xinjiang Key Laboratory of Clinical Genetic Testing and Biomedical Information, Karamay, 834099, China.; Xinjiang Clinical Research Center for Precision Medicine of Digestive System Tumor, Karamay, 834099, China.; Department of Pathology, Karamay Central Hospital, Karamay, 834099, China.
Lv X; College of Software, Xinjiang University, Urumqi, 830046, China. .; College of Information Science and Engineering, Xinjiang University, Urumqi, 830046, China. .; Key Laboratory of Signal Detection and Processing, Xinjiang University, Urumqi, 830046, China. .; Xinjiang Cloud Computing Application Laboratory, Karamay, 834099, China. .
Ma Y; Xinjiang Key Laboratory of Clinical Genetic Testing and Biomedical Information, Karamay, 834099, China. .; Xinjiang Clinical Research Center for Precision Medicine of Digestive System Tumor, Karamay, 834099, China. .; Department of Pathology, Karamay Central Hospital, Karamay, 834099, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6209. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*
Adenocarcinoma*
Data Compression*
Lung Neoplasms*/diagnosis
Humans ; Benchmarking
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pulmonary Adenocarcinoma In Situ and Minimally Invasive Adenocarcinomas in European Patients Have Less KRAS and More EGFR Mutations Compared to Advanced Adenocarcinomas.
Autorzy:
Petterson J; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Mustafa D; Department of Medical Chemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.
Bandaru S; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Eklund EÄ; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Clinical Oncology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Hallqvist A; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Clinical Oncology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.
Sayin VI; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, 413 45 Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden.
Gagné A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Fagman H; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.; Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.
Akyürek LM; Department of Clinical Pathology, Sahlgrenska University Hospital, Västra Götalandsregionen, 413 45 Gothenburg, Sweden.; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sahlgrenska Academy, 405 30 Gothenburg, Sweden.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 03; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma in Situ*/genetics
Adenocarcinoma in Situ*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma*/pathology
Lung Neoplasms*/metabolism
Humans ; Proto-Oncogene Proteins p21(ras)/genetics ; Mutation ; ErbB Receptors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Radiological and clinical features of large consolidative-type pulmonary invasive mucinous adenocarcinoma.
Autorzy:
Chen J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Qi L; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue L; Department of Diagnostic Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xue Q; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jia J; Department of Diagnostic Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang G; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li F; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cui S; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2024 Mar; Vol. 18 (3), pp. e13743.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Lung Neoplasms*/drug therapy
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/pathology
Adenocarcinoma, Mucinous*/diagnostic imaging
Adenocarcinoma, Mucinous*/genetics
Adenocarcinoma, Mucinous*/drug therapy
Humans ; Lymphatic Metastasis ; Retrospective Studies ; Proto-Oncogene Proteins p21(ras)/genetics ; Prognosis ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system.
Autorzy:
Wang S; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Y; Ping An Healthcare Technology, Beijing, China.
Sun X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Dong J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Department of Pathology, the 5th Affiliated Hospital of Qiqihar Medical College/Longnan Hospital, Daqing, China.
Chen R; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li F; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen T; Ping An Healthcare Technology, Beijing, China.
Li X; Ping An Healthcare Technology, Beijing, China.
Xie G; Ping An Healthcare Technology, Beijing, China.; Ping An Health Cloud Company Limited, Beijing, China.; Ping An International Smart City Technology Co, Beijing, China.
Ying J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guo Q; Big data office, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Mao Y; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 519-528. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/pathology
Humans ; Retrospective Studies ; Reproducibility of Results ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis.
Autorzy:
Zhao T; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Yi J; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Luo D; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine and University Hospital, Macau University of Science and Technology, Taipa, 999078, Macao, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Liu J; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China.
Fan X; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .
Wu Q; Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine and University Hospital, Macau University of Science and Technology, Taipa, 999078, Macao, China. .; Zhuhai MUST Science and Technology Research Institute, 51900, Zhuhai, Guangdong, China. .
Wang W; Department of Respiratory and Critical Care Medicine, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .; Inflammation & Allergic Diseases Research Unit, The Affiliated Hospital, Southwest Medical University, 646099, Luzhou, Sichuan, China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2024 Feb 02; Vol. 22 (1), pp. 41. Date of Electronic Publication: 2024 Feb 02.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/pathology
Adenocarcinoma, Mucinous*/surgery
Adenocarcinoma, Mucinous*/pathology
Lung Neoplasms*/pathology
Pneumonia*/pathology
Humans ; Lung/pathology ; Lymphatic Metastasis ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Male ; Female
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Autorzy:
Huang Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Chen D; Tianjin First Central Hospital Clinic Institute, Tianjin Medical University, Tianjin, 300192, China.
Bai Y; Department of Hepatobiliary Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China.
Zhang Y; Department of Hepatobiliary Surgery, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China.
Zheng Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Fu Q; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Yi B; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Jiang Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Zhang Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. .
Zhu J; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 452. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*
Colonic Neoplasms*
Pancreatic Neoplasms*
Carcinoma, Hepatocellular*
Carcinoma, Renal Cell*/genetics
Adenocarcinoma of Lung*
Thymus Neoplasms*
Liver Neoplasms*
Kidney Neoplasms*
Lung Neoplasms*
Adrenal Cortex Neoplasms*
Humans ; Acetyltransferases ; Chromosomal Proteins, Non-Histone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Elucidating the role of EPPK1 in lung adenocarcinoma development.
Autorzy:
Arimura K; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Kammer M; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Rahman SMJ; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Sheau-Chiann C; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Zhao S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Heidi C; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Eisenberg R; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Zou Y; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Antic S; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Richmond B; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Tagaya E; Department of Respiratory Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Grogan E; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Massion P; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Maldonado F; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 10; Vol. 24 (1), pp. 441. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/pathology
Adenocarcinoma*/pathology
Humans ; Epithelial-Mesenchymal Transition/genetics ; Prognosis ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A nomogram based on the quantitative and qualitative features of CT imaging for the prediction of the invasiveness of ground glass nodules in lung adenocarcinoma.
Autorzy:
Yang Y; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Xu J; Department of Dermatology and Venereal Diseases, Yan'an Hospital of Kunming City, Kunming, China.
Wang W; Department of Thoracic and Cardiovascular Surgery, Shiyan Taihe Hospital (Hubei University of Medicine), Hubei, Shiyan, China.
Ma M; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Huang Q; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Zhou C; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Zhao J; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Duan Y; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China.
Luo J; Department of Pathology, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Jiang J; Department of Radiology, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Ye L; Department of Thoracic and Cardiovascular Surgery, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, No. 519 Kunzhou Road, Xishan District, Yunnan Province, Kunming, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 09; Vol. 24 (1), pp. 438. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/surgery
Adenocarcinoma of Lung*/pathology
Humans ; Nomograms ; Tomography, X-Ray Computed/methods ; Neoplasm Invasiveness/pathology ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Monolayer culture alters EGFR inhibitor response through abrogation of microRNA-mediated feedback regulation.
Autorzy:
Florio A; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
Johnson S; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Salvatori R; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Vasmatzis G; Biomarker Discovery Laboratory, Center for Individualized Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. .; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7303. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/metabolism
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Antineoplastic Agents*/pharmacology
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Humans ; Erlotinib Hydrochloride/pharmacology ; Erlotinib Hydrochloride/therapeutic use ; Feedback ; ErbB Receptors/metabolism ; Cell Line, Tumor ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Drug Resistance, Neoplasm ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical characteristics and MRI based radiomics nomograms can predict iPFS and short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung adenocarcinoma with brain metastases.
Autorzy:
Qi H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Hou Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Zheng Z; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Zheng M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Qiao Q; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Wang Z; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China.
Sun X; Department of Nuclear Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Science, Jinan, Shandong, China.
Xing L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, Shandong, 250117, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 21; Vol. 24 (1), pp. 362. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Genes, erbB-1 ; Nomograms ; Progression-Free Survival ; Radiomics ; Magnetic Resonance Imaging ; ErbB Receptors/genetics ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A new model using deep learning to predict recurrence after surgical resection of lung adenocarcinoma.
Autorzy:
Kim PJ; School of Dentistry and Dental Research Institute, Seoul National University, Seoul, Republic of Korea.
Hwang HS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Choi G; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Sung HJ; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Ahn B; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Uh JS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Yoon S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim D; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Chun SM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Jang SJ; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Go H; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 16; Vol. 14 (1), pp. 6366. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Deep Learning*
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Humans ; Neoplasm Recurrence, Local/pathology ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Autorzy:
Ge W; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.; Department of Medical Oncology, Shanghai Medical College, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, People's Republic of China.
Wang Y; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Quan M; Department of Oncology and Tumor Institute, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. .
Mao T; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Bischof EY; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Xu H; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Zhang X; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Li S; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Yue M; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Ma J; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Yang H; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Wang L; Department of Oncology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Jiangsu, China.
Yu Z; Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. .
Wang L; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. .
Cui J; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Mar 08; Vol. 23 (1), pp. 48. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Lung Neoplasms*/pathology
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/pathology
Humans ; ARNTL Transcription Factors/metabolism ; Biomarkers/metabolism ; Cell Line, Tumor ; ErbB Receptors/metabolism ; Erlotinib Hydrochloride/pharmacology ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphorylation ; Precision Medicine ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mesonephric-like adenocarcinoma of the ovary.
Autorzy:
Yang Y; Dalian Medical University, Dalian, 116000, PR China.
Zhao M; Dalian Medical University, Dalian, 116000, PR China.
Jia Q; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Tang H; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Xing T; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Li Y; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Tang B; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Xu L; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Wei W; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Zheng H; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Shi R; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China.
Xia B; Department of Gynecological Oncology, Division of Life Sciences and Medicine, the First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, 230031, PR China. .
Chen J; Department of Gynecology, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, 213003, PR China. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Mar 05; Vol. 17 (1), pp. 57. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnosis
Ovarian Neoplasms*/therapy
Adenocarcinoma*/diagnosis
Adenocarcinoma*/therapy
Female ; Humans ; Middle Aged ; Pelvis ; Carboplatin
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: potential therapeutic targets.
Autorzy:
Dong Z; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Chong W; Precision Medicine Center, Yangtze Delta Region Institute of Tsinghua University, Jiaxing, Zhejiang, China.
Chen C; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Qi L; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Mengke L; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Minghui D; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Jiawei Y; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Longxi Q; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Hengchao L; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China.
Liu J; Department of Precision medicine, Accb Biotech.Ltd, Beijing, China.
Zhimin G; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi Province, 710061, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 04; Vol. 24 (1), pp. 286. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Duodenal Neoplasms*
Pancreatic Neoplasms*
Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Common Bile Duct Neoplasms*
Humans ; B7-H1 Antigen ; Phosphatidylinositol 3-Kinases ; Genomics ; China/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sinonasal adenocarcinoma presented as a giant anterior cranial fossa mass: a case report and review of the literature.
Autorzy:
Ali EH; Department of Neurosurgery, St. Paul's Millennium Medical College, Addis Ababa, Ethiopia. .
Mengesha MW; St. Paul's Millennium Medical College Hospital, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Mar 04; Vol. 18 (1), pp. 85. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/therapy
Paranasal Sinus Neoplasms*/diagnostic imaging
Paranasal Sinus Neoplasms*/therapy
Humans ; Male ; Middle Aged ; Cranial Fossa, Anterior/diagnostic imaging ; Anosmia ; Brain
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target.
Autorzy:
Chen M; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China.
Zhang S; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Wang F; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
He J; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China.
Jiang W; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, Guangxi, People's Republic of China. .
Zhang L; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Feb 27; Vol. 22 (1), pp. 209. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Urea*/analogs & derivatives
Humans ; Benzimidazoles ; Neoplasm Proteins ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
Autorzy:
de Moraes FCA; Federal University of Pará, 66073-005, Belém, Pará, Brazil. .
Pasqualotto E; Federal University of Santa Catarina, 88040-900, Florianópolis, Santa Catarina, Brazil.
Chavez MP; Federal University of Santa Catarina, 88040-900, Florianópolis, Santa Catarina, Brazil.
Ferreira ROM; Federal University of Santa Catarina, 88040-900, Florianópolis, Santa Catarina, Brazil.
De Castria TB; Moffitt Cancer Center, 12902 USF Magnolia Drive, 33612, Tampa, FL, USA.; Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., 33612, Tampa, FL, USA.
Burbano RMR; Ophir Loyola Hospital, 66063-240, Belém, Pará, Brazil.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 21; Vol. 24 (1), pp. 240. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Stomach Neoplasms*/pathology
Adenocarcinoma*/pathology
Esophageal Neoplasms*
Humans ; Randomized Controlled Trials as Topic ; Antibodies, Monoclonal/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Esophagogastric Junction/pathology ; Claudins
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma.
Autorzy:
Marcazzan S; II. Medizinische Klinik, TUM School of Medicine and Health, Klinikum Rechts der Isar at Technical University of Munich, Munich, 81675, Germany.; Institute of Biological and Medical Imaging, Helmholtz Zentrum München, 85764 Neuherberg, Germany and Chair of Biological Imaging at the Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.; Clinical Radiology, Medical School OWL, Bielefeld University, Bielefeld, 33615, Germany.
Braz Carvalho MJ; II. Medizinische Klinik, TUM School of Medicine and Health, Klinikum Rechts der Isar at Technical University of Munich, Munich, 81675, Germany.
Nguyen NT; Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum Rechts der Isar at Technical University of Munich, Munich, 81675, Germany.; Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.
Strangmann J; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, 79106, Germany.
Slotta-Huspenina J; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.
Tenditnaya A; Institute of Biological and Medical Imaging, Helmholtz Zentrum München, 85764 Neuherberg, Germany and Chair of Biological Imaging at the Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.
Tschurtschenthaler M; Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.; Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, 69120, Germany.; Chair of Translational Cancer Research and Institute of Experimental Cancer Therapy, TUM School of Medicine and Health, Klinikum rechts der Isar at Technical University of Munich, Munich, 81675, Germany.
Rieder J; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, 79106, Germany.
Proaño-Vasco A; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, 79106, Germany.
Ntziachristos V; Institute of Biological and Medical Imaging, Helmholtz Zentrum München, 85764 Neuherberg, Germany and Chair of Biological Imaging at the Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.
Steiger K; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.; Comparative Experimental Pathology (CEP) and IBioTUM tissue biobank, TUM School of Medicine and Health, Technical University of Munich, München, 81675, Germany.
Gorpas D; Institute of Biological and Medical Imaging, Helmholtz Zentrum München, 85764 Neuherberg, Germany and Chair of Biological Imaging at the Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany.
Quante M; Department of Medicine II (Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, 79106, Germany. .
Kossatz S; Department of Nuclear Medicine, TUM School of Medicine and Health, Klinikum Rechts der Isar at Technical University of Munich, Munich, 81675, Germany. .; Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich, Munich, 81675, Germany. .; Department of Chemistry, TUM School of Natural Sciences, Technical University of Munich, Munich, 85748, Germany. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 21; Vol. 43 (1), pp. 53. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/genetics
Barrett Esophagus*/diagnosis
Barrett Esophagus*/genetics
Barrett Esophagus*/pathology
Adenocarcinoma*/diagnostic imaging
Adenocarcinoma*/genetics
Humans ; Mice ; Animals ; Early Detection of Cancer ; Mice, Transgenic ; Endoscopy ; Poly (ADP-Ribose) Polymerase-1/genetics
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The association of genomic alterations with PD-L1 expression in Chinese patients with EGFR/ALK wild-type lung adenocarcinoma and potential predictive value of Hippo pathway mutations to immunotherapy.
Autorzy:
Liu F; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Lu M; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu C; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
Zhang X; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chen Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang P; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7038.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/therapy
Lung Neoplasms*/therapy
Lung Neoplasms*/drug therapy
Humans ; Anaplastic Lymphoma Kinase/genetics ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; China ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Genomics ; Hippo Signaling Pathway/genetics ; Immunotherapy ; Mutation ; Retrospective Studies ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 165385

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies